Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)
Compose a Response to This Article
Other responses
No responses have been published for this article.